您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[中航证券]:上半年业绩承压,创新+国际化战略稳步推进 - 发现报告
当前位置:首页/公司研究/报告详情/

上半年业绩承压,创新+国际化战略稳步推进

恒瑞医药,6002762022-08-21沈文文中航证券有***
上半年业绩承压,创新+国际化战略稳步推进

1 ◆ ◆ ◆ ◆ ◆ ◆ ◆ 报表预测单位:百万元会计年度2019202020212022E2023E2024E利润表 营业收入23,288.5827,734.6025,905.5325,629.9928,330.6631,346.21 减: 营业成本2,912.943,348.693,741.803,497.004,003.594,553.94 税金及附加216.34256.96201.81199.66220.70244.19 主营业务利润20,159.2924,128.9521,961.9221,933.3324,106.3826,548.09 减: 销售费用8,524.979,802.529,383.719,226.809,972.3910,971.17 管理费用2,241.183,066.662,860.312,793.673,031.383,322.70 研发费用3,896.344,988.965,943.315,894.906,275.246,896.17 财务费用-133.82 -181.74 -337.96 -49.00 -65.46 -81.86 经营性利润5,630.636,452.554,112.564,066.974,892.825,439.90 加: 资产减值损失-5.47 -7.28 -13.86 0.000.000.00 信用减值损失-13.23 -6.70 4.05-5.58 -6.17 -6.83 其他经营损益0.00-0.00 0.000.000.000.00 投资收益309.27341.42213.43216.90216.33216.04 公允价值变动损益37.5316.5036.230.000.000.00 资产处置收益1.242.983.372.893.063.06 其他收益189.71207.59309.04255.33265.28269.26 营业利润6,149.687,007.074,664.824,536.515,371.325,921.43 加: 其他非经营损益0.000.000.000.000.000.00 营业外收入0.811.072.221.601.721.76 减: 营业外支出94.73112.66200.73153.71162.54165.96 利润总额6,055.766,895.484,466.314,384.405,210.505,757.23 减: 所得税729.31586.59-17.72 -0.00 -0.00 -0.00 净利润5,326.456,308.894,484.034,384.405,210.505,757.23 减: 少数股东损益-1.58 -19.49 -46.19 -27.31 -36.80 -42.17 归属母公司股东净利润5,328.036,328.384,530.224,411.725,247.305,799.40资产负债表 货币资金5,043.6510,804.6713,630.8218,130.3922,128.4226,571.66 交易性金融资产8,519.805,628.005,090.355,090.355,090.355,090.35 应收票据528.560.001,081.03550.41608.41673.17 应收账款4,906.258,175.725,802.906,232.006,888.687,621.92 预付账款591.16562.11973.02710.91785.82869.46 其他应收款894.38651.15658.00745.68824.25911.99 存货1,606.811,778.062,402.672,010.422,301.662,618.05 其他流动资产220.71450.32548.95400.72442.94490.09 长期股权投资60.0060.00192.83189.36185.31180.97 金融资产投资539.431,442.46807.86807.86807.86807.86 投资性房地产0.000.000.000.000.000.00 固定资产和在建工程4,074.804,585.246,275.606,267.245,942.455,375.12 无形资产和开发支出349.76341.25702.44621.47533.29437.88 其他非流动资产221.18250.601,099.75945.05790.36790.36 资产总计27,556.4834,729.5939,266.2242,701.8647,329.7952,438.87 短期借款0.000.000.000.000.000.00 交易性金融负债0.000.000.000.000.000.00 应付票据0.00106.49465.64182.13208.51237.17 应付账款1,289.251,326.251,787.141,534.321,756.581,998.05 预收账款222.640.000.0081.6790.2899.89 合同负债0.00358.06219.55182.70201.95223.45 其他应付款960.751,972.61914.151,355.901,552.321,765.71 长期借款0.000.00151.59119.7486.1852.73 其他负债146.31179.19156.35148.95149.62150.50 负债合计2,618.953,942.593,694.413,605.424,045.454,527.50 股本4,422.815,331.726,396.016,396.016,396.016,396.01 资本公积1,662.973,142.833,356.183,356.183,356.183,356.18 留存收益18,689.5422,029.7625,250.7628,802.7233,027.4237,696.62 归属母公司股东权益24,775.3230,504.3035,002.9638,554.9242,779.6147,448.82 少数股东权益162.20282.70568.85541.53504.73462.56 股东权益合计24,937.5330,787.0035,571.8139,096.4543,284.3447,911.37 负债和股东权益合计27,556.4834,729.5939,266.2242,701.8647,329.7952,438.87 投入资本(IC)15,878.3023,716.5326,556.5825,439.5926,676.1628,032.72现金流量表 资本支出484.89529.651,694.34800.00600.00500.00 自由现金流8,487.402,831.783,662.385,597.944,061.914,475.29 短期借款增加0.000.000.000.000.000.00 长期带息债务增加0.000.00151.59-31.84 -33.56 -33.45 股权筹资额0.000.000.00 支付普通股股利1,017.131,066.251,020.47859.761,022.601,130.20 长期投资-1,385.29 2,348.601,102.26204.26200.99198.82 经营性现金净流量3,816.833,431.934,218.825,935.025,384.685,823.16 投资性现金净流量-1,945.44 1,797.83-546.26 -592.85 -395.95 -298.12 筹资性现金净流量-718.51 291.19-998.32 -842.61 -990.71 -1,081.79 现金流量净额1,165.195,431.872,657.364,499.573,998.034,443.25 货币资金的期初余额3,865.735,030.9210,462.7913,630.8218,130.3922,128.42 货币资金的期末余额5,043.6510,804.6713,630.8218,130.3922,128.4226,571.66 企业自由现金流8,487.402,831.783,662.385,597.944,061.914,475.29 权益自由现金流8,605.102,998.064,153.275,615.294,094.074,524.03